Early-stage prostate cancer clinical trial is now enrolling
If you have been diagnosed with prostate cancer, enrollment is underway for a clinical research trial specifically designed for men with early-stage prostate cancer that has not spread to other parts of the body.
EMBARK CLINICAL TRIAL
This clinical study is evaluating the potential benefits and risks of the investigational drug enzalutamide in the treatment of men whose prostate cancer has not spread to other parts of the body, otherwise known as nonmetastatic prostate cancer.
Enzalutamide is an androgen receptor inhibitor being studied for its potential to work at the cellular level inside a tumor to prevent the steps necessary for the tumor to continue to grow.